← All trials
NCT07263594
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2025
- Primary completion
- Dec 31, 2028
- Completion date
- Dec 31, 2028
- First posted
- Dec 4, 2025
- Last posted
- Dec 4, 2025
- Enrollment
- 127
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- DualityBio Inc.Lead sponsor
- DualityBio Inc.Official
- GlaxoSmithKlineCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.